Indolizine derivatives and their application in medicine
US11021478B2 · kind B2 · utility
2Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2018 |
| Grant date | Jun 1, 2021 |
| Priority date | — |
| Expiry date | Jun 4, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to indolizine derivatives and their use in medicine. In particular, the present invention discloses novel substituted indolizine derivatives of formula I, or an isotopically labeled compound thereof, or an optical isomer thereof, a geometric isomer thereof, a tautomer thereof or a mixture of various isomers, or a pharmaceutically acceptable salt thereof, or a prodrug thereof. The invention also relates to the use of these compounds in medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.